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background:  AMI has become a major cause of hospitalization and mortality in China over the last 2 decades. The unbalanced economy 
and disparate medical care have the potential to lead to variation in treatment and outcomes across different-level hospitals.
methods:  The China AMI registry consists of 108 hospitals across three levels (province, prefecture and county) throughout Mainland 
China. Treatment and adjusted in-hospital outcomes were compared across hospital levels.
Results:  In total, 16,652 patients with AMI were primarily admitted to hospital. During the hospitalization, aspirin, P2Y12 receptor inhibitor 
and statin uses were high (84-98%). However, the rates of reperfusion in STEMI and coronary revascularization in NSTEMI were 
significantly lower in patients admitted to smaller hospitals (Fig A). The modality of reperfusion was primary PCI in 94% of patients in 
provincial hospitals, compared to 76% in prefecture and 37% in county hospitals. After adjustment for clinical characteristics, the risk of in-
hospital mortality was higher in smaller hospitals for STEMI patients [adj OR 1.31 (95%CI 0.94-1.84) and 2.15 (1.46-3.18) in prefecture and 
county hospitals vs. provincial hospitals] but not for NSTEMI patients (Fig B).
conclusion:  Significant variations in treatment were observed for AMI patients across different levels of hospitals in China. Disparities in 
observed rates of in-hospital mortality suggest that further research and quality improvement efforts in AMI are needed in China.
 
